The Office of Technology Licensing was established in 1970 to transfer technologies developed at Stanford. Find out more about OTL's history, mission, staff, and statistics.

Login to TechFinder » 

If your browser is not displaying images correctly, try clearing your cookies and cache to solve the problem.

Login and Registration
You are not logged into the OTL TechFinder web site. If you are already registered, please login. Otherwise, registration is free and entitles you to receive emails and correspondence about new technology releases.

Would you like to find out about other ways to engage with Stanford?
If so, please visit http://corporate.stanford.edu/.

Validation of new protein analysis methodology through conditional transgenic mouse models

Stanford researchers have developed the use of a nano-fluidic proteomic immunoassay (NIA) to quantify total and phosphorylated forms of oncoproteins in nanoscale tumor samples. They developed NIA by combining the use of an automated microfluidic instrumen...
more information »

A peptide inhibitor for treating Alzheimer's disease

Alzheimer’s disease (AD) is the most common neurodegenerative disease and the leading cause of dementia in the elderly. Increasing evidence points to soluble amyloid-β (Aβ) oligomers as the prime causative agent in AD progression and pinpoints synapse...
more information »

What is TechFinder?
By clicking the links above you can search the database for opportunities and submit requests for additional information. TechFinder contains text and images. TechFinder is updated within minutes of any changes made at Stanford's Office of Technology Licensing.